Actively Recruiting
A Chatbot-based Program to Promote Well-being in Caregivers of Children With Autism Spectrum Disorder
Led by Hong Kong Metropolitan University · Updated on 2025-12-17
130
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a Chatbot-based program designed to promote well-being in caregivers of children with Autism Spectrum Disorder (ASD). ASD involves challenges in social communication, cognitive development, behavior patterns, and sensory processing. Caring for children with ASD can be stressful and impact parents' mental health, which in turn affects the success of early interventions for their children. This study aims to improve caregivers' well-being, reduce stress and depressive symptoms, and enhance quality of life through this innovative digital approach. The study involves a randomized controlled trial where 130 caregivers of children aged 6 to 11 years with ASD will be assigned to either the Chatbot intervention group or a control group receiving one-page information about ASD. The Chatbot uses conversational AI with modules focusing on positive psychology exercises, useful information on healthcare and community resources, and peer networks for sharing experiences. The intervention is designed to be accessible, personalized, and available at any time to support caregivers. Participants will be assessed at baseline, 3 months, and 6 months for well-being, depressive symptoms, quality of life, parenting stress, and the feasibility of using the Chatbot. Caregivers will communicate with the Chatbot as part of the intervention, while control participants receive only informational material. The study will monitor outcomes over the six-month period to evaluate the program's impact on mental health and caregiving experiences.
CONDITIONS
Brief Title
A Chatbot-based Program to Promote Well-being in Caregivers of Children With Autism Spectrum Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Caregivers providing long-term care for children diagnosed with Autism Spectrum Disorder confirmed by qualified clinician documentation
- Caregivers of primary-school-age children between 6 and 11 years old
- Caregivers aged over 18 years old
- Caregivers able to communicate and read in Chinese
You will not qualify if you...
- Unwillingness to complete questionnaires at three time points
- Diagnosis of severe psychiatric disorders such as schizophrenia or severe bipolar disorder, or cognitive impairment
- Participation in a similar psychological intervention within one year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 6 months
Participants in the experimental group communicate with the Chatbot, which includes modules on individual strength, information, and peer networks. Participants in the control group receive one-page health information about ASD.
3 visits at baseline, 3 months, and 6 months
Trial Site Locations
Total: 1 location
1
Hong Kong Metropolitan University
Hong Kong, Hong Kong
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here